PATENT CLAIM ANALYSIS

Application Number: 15866895
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "239100"]

Abstract:
The present disclosure relates to chimeric neurotoxins and uses thereof. In particular, provided herein are chimeric botulinum neurotoxins with altered properties and uses thereof (e.g., research, screening, and therapeutic uses).

Claim (Index 3):
The molecule of  claim 1 , wherein said molecule has a subtype selected from the group consisting of A1/A2, A1/A3, A1/A4, A1/A5, A1/A6, A1/A7, A1/A8, A1/A9, A1/A10, A2/A1, A2/A3, A2/A4, A2/A5, A2/A6, A2/A7, A2/A8, A2/A9, A2/A10, A3/A1, A3/A2, A3/A4, A3/A5, A3/A6, A3/A7, A3/A8, A3/A9, A3/A10, A4/A1, A4/A2, A4/A3, A4/A5, A4/A6, A4/A7, A4/A8, A4/A9, A4/A10, A5/A1, A5/A2, A5/A3, A5/A4, A5/A6, A5/A7, A5/A8, A5/A9, A5/A10, A6/A1, A6/A2, A6/A3, A6/A4, A6/A5, A6/A7, A6/A8, A6/A9, A6/A10, A7/A1, A7/A2, a7/A3, A7/A4, A7/A5, A7/A6, A7/A8, A7/A9, A7/A10, A8/A1, A8/A2, A8/A3, A8/A4, A8/A5, A8/A6, A8/A7, A8/A9, A8/A10, A9/A1, A9/A2, A9/A3, A9/A4, A9/A5, A9/A6, A9/A7, A9/A8, A9/A10, A10/A1, A10/A2, A10/A3, A10/A4, A10/A5, A10/A6, A10/A7, A10/A8, and A10/A9.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 86.0
- Lexical Diversity: 1.40741
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13131792', '11230330', '15082158', '12769754', '14347074']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7671180747725271
- 35 USC 102 Novelty (BERT): 0.5312796580119975
- Combined Prediction Score: 0.7435342330964742
- Mean Citation Score: 325.8573800000001
- Max Citation Score: 336.55664
- Similarity Product: 216.2360909370041

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test